DalsnaFinance › IPOs › Intellia Therapeutics Inc › IPO
Intellia Therapeutics, Inc. completed its initial public offering on NASDAQ on May 6, 2016, pricing at $18.00 a share.
| Ticker | NTLA |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | May 6, 2016 |
| Offering price | $18.00 |
| Shares offered | 6,000,000 |
| Total raised | $108M |
Intellia Therapeutics, Inc. sold 6,000,000 shares at $18.00 each on NASDAQ. Multiplied out, that is $108 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $108 million total recorded for the deal.
Intellia Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Intellia Therapeutics, Inc.. This page is general information, not investment advice.